Abstract:The cannabinoid receptor 2 (CB2) plays an important role in the immune system. Although a few of GPCRs crystallographic structures have been reported, it is still challenging to obtain functional transmembrane proteins and high resolution X-ray crystal structures, such as for the CB2 receptor. In the present work, we used 10 reported crystal structures of GPCRs which had high sequence identities with CB2 to construct homology-based comparative CB2 models. We applied these 10 models to perform a prescreen by using a training set consisting of 20 CB2 active compounds and 980 compounds randomly selected from the National Cancer Institute (NCI) database. We then utilized the known 170 cannabinoid receptor 1 (CB1) or CB2 selective compounds for further validation. Based on the docking results, we selected one CB2 model (constructed by β1AR) that was most consistent with the known experimental data, revealing that the defined binding pocket in our CB2 model was well-correlated with the training and testing data studies. Importantly, we identified a potential allosteric binding pocket adjacent to the orthosteric ligand-binding site, which is similar to the reported allosteric pocket for sodium ion Na(+) in the A2AAR and the δ-opioid receptor. Our studies in correlation of our data with others suggested that sodium may reduce the binding affinities of endogenous agonists or its analogs to CB2. We performed a series of docking studies to compare the important residues in the binding pockets of CB2 with CB1, including antagonist, agonist, and our CB2 neutral compound (neutral antagonist) XIE35-1001. Then, we carried out 50 ns molecular dynamics (MD) simulations for the CB2 docked with SR144528 and CP55940, respectively. We found that the conformational changes of CB2 upon antagonist/agonist binding were congruent with recent reports of those for other GPCRs. Based on these results, we further examined one known residue, Val113(3.32), and predicted two new residues, Phe183 in ECL2 and Phe281(7.35), that were important for SR144528 and CP55940 binding to CB2. We then performed site-directed mutation experimental study for these residues and validated the predictions by radiometric binding affinity assay.

A homology modeling study toward the understanding of three-dimensional structure and putative pharmacological profile of the G-protein coupled receptor GPR55.

Structure basis of ligand recognition and activation of GPR55

GPR55, a Lysophosphatidylinositol Receptor with Cannabinoid Sensitivity?

Computational Investigations on the Binding Mode of Ligands for the Cannabinoid-Activated G Protein-Coupled Receptor GPR18

GPR55 – a putative “type 3” cannabinoid receptor in inflammation

Toward the Three-Dimensional Structure and Lysophosphatidic Acid Binding Characteristics of the LPA(4)/p2y(9)/GPR23 Receptor: a Homology Modeling Study.

G Protein-Coupled Estrogen Receptor (Gper) Agonist Dual Binding Mode Analyses Toward Understanding Of Its Activation Mechanism: A Comparative Homology Modeling Approach

Modeling, Molecular Dynamics Simulation, and Mutation Validation for Structure of Cannabinoid Receptor 2 Based on Known Crystal Structures of GPCRs

Homology modeling and molecular dynamics simulations of the mu opioid receptor in a membrane-aqueous system.

The orphan receptor GPR55 is a novel cannabinoid receptor

New Insights in Cannabinoid Receptor Structure and Signaling

Ligand-specific homology modeling of human cannabinoid (CB1) receptor

Study on the antagonists for the orphan G protein-coupled receptor GPR55 by quantitative structure–activity relationship

Structural basis of ligand recognition and self-activation of orphan GPR52

Toward a Structural Understanding of Class B GPCR Peptide Binding and Activation.

Molecular Modeling and Molecular Dynamics Simulation-Based Structural Analysis of GPR3.

Activation and Allosteric Regulation of the Orphan GPR88-Gi1 Signaling Complex.

G-Protein-Coupled Receptor 120-GPR120: Molecular Modeling Studies

Similarity between class A and class B G-protein-coupled receptors exemplified through calcitonin gene-related peptide receptor modelling and mutagenesis studies

Homology Modeling and Molecular Docking of Human Pituitary Adenylate Cyclase-Activating Polypeptide I Receptor

Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor.